ArticleTranslational psychiatry2026
sCMOS-based fNIRS system: validation via optical performance and cortical response.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Functional near-infrared spectroscopy (fNIRS) is a non-invasive neuroimaging technique for assessing cerebral function, combining excellent ecological validity with high temporal resolution. However, despite the advantages of fNIRS, challenges remain including insufficient spatial resolution, and bulkiness-issues that conventional fNIRS devices inadequately address, particularly given the notable increase in equipment bulk and costs associated with enhancing resolution by increasing the number of detectors. In this study, we propose a scientific complementary metal-oxide-semiconductor (sCMOS) sensor as a viable alternative to fNIRS detectors. The sCMOS sensor offers a two-dimensional array sensor that replaces the traditional configuration of multiple diode-lock-in amplifiers, significantly reducing both the size and cost of the devices. However, this raises a crucial question: can the sCMOS sensor effectively substitute traditional detectors while maintaining comparable accuracy to the weak scattered light characteristic of fNIRS? To address this question, we conducted comprehensive validation through both in vitro optical performance (including scattering-absorption and blood-doped tissue-simulating phantoms) and in vivo cortical response. Our results demonstrate that the developed sCMOS-based fNIRS system achieves detection performance comparable to conventional fNIRS technologies, indicating strong potential for translational applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.